LT-630

• Description :

  LT-630 is a HDAC6 inhibitor. LT-630 ameliorates liver injury by reducing oxidative damage[1].

• UNSPSC :

  12352005

• Target :

  HDAC

• Type :

  Reference compound

• Related Pathways :

  Cell Cycle/DNA Damage; Epigenetics

• Applications :

  COVID-19-anti-virus

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/lt-630.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(NO)C1=CC=C(CN2N=C(C(NC3=CC(F)=CC=C3)=O)C=C2C)C=C1

• Molecular Formula :

  C19H17FN4O3

• Molecular Weight :

  368.36

• References & Citations :

  [1]Zhang GD, et al. A novel HDAC6 inhibitor attenuate APAP-induced liver injury by regulating MDH1-mediated oxidative stress. Int Immunopharmacol. 2024 Mar 13;131:111861.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  HDAC6